A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...